Weight & Metabolic

How to Appeal a Denial of GLP-1 Weight-Loss Medication Coverage, Step by Step

By the US Health Digest editorial team · July 24, 2026

If your plan denied coverage for a GLP-1 medication, you generally have a legal right to appeal — first inside the plan, then to an independent outside reviewer. The process runs on deadlines, and it differs depending on whether you have commercial insurance, Medicare Part D, or Medicaid. Before anything else, find out which kind of denial you received: "not medically necessary" and "this plan excludes weight-loss drugs" are different problems with different next steps. This article describes the processes as government sources describe them; it is not legal or medical advice.

First: what does the denial letter actually say?

Federal rules require insurers to explain themselves. As healthcare.gov puts it, insurance companies "have to tell you why they've denied your claim or ended your coverage" and "have to let you know how you can dispute their decisions." In practice, the denial notice should tell you three things:

• The reason for the denial — the specific ground the plan is standing on (for example, prior authorization criteria not met, or the drug is not a covered benefit).
• How to dispute it — the plan's internal appeal instructions and where to send them.
• What comes after an internal denial — the plan's final internal determination "must tell you how to ask for an external review," per healthcare.gov.

Read the stated reason carefully, because it determines everything below.

Two very different denials — and honest odds

Denial type A: "not medically necessary" or prior authorization failed

Here the plan covers GLP-1s for weight management in principle but says you don't meet its criteria — a BMI threshold, documentation of prior weight-management attempts, or a step-therapy requirement. This is the denial appeals were built for. It turns on medical judgment, which is exactly the category healthcare.gov lists as eligible for independent external review: denials that "involve medical judgment" where you or your provider may disagree with the plan.

Denial type B: your plan excludes weight-loss drugs as a category

Many GLP-1 denials are not about you at all — the plan simply doesn't include weight-loss medications in its benefit. In the KFF 2025 Employer Health Benefits Survey, only 19% of firms with 200 or more workers covered GLP-1s for weight loss in their largest health plan (16% of firms with 200–999 workers, 30% with 1,000–4,999, and 43% with 5,000+), and 34% of covering firms required participation in a lifestyle program or meetings with a dietitian, case manager, or therapist as a condition of coverage.

Be realistic: a true benefit exclusion is generally not a medical-judgment dispute, so a medical-necessity appeal usually cannot overturn it — no letter from your doctor changes what the contract covers. Confirm the exclusion in your plan documents (the Summary of Benefits and Coverage and the formulary), ask the plan in writing whether any exception process exists, and if not, focus your energy on the alternatives in the last section. Whether your health situation involves a condition the plan does cover is a clinical question for your prescriber — never ask anyone to change how a diagnosis is coded to fit coverage; misrepresenting a diagnosis to an insurer is fraud.

The commercial and Marketplace track: internal appeal, then external review

If you have a Marketplace plan or most employer coverage, healthcare.gov describes two stages.

Stage 1: internal appeal

You ask the plan for "a full and fair review of its decision," as the main healthcare.gov appeals page puts it. Per healthcare.gov: you must file within 180 days (6 months) of receiving the denial; the plan must complete the appeal within 30 days if it's for a service you haven't received yet (the usual GLP-1 prior-authorization situation) or within 60 days for services already received; and urgent appeals must be decided "as quickly as your medical condition requires," and at least within 4 business days.

Stage 2: external review

If the internal appeal fails, an independent third party can review the decision — "the insurance company no longer gets the final say," per healthcare.gov. Per the external review page: file a written request within 4 months of the final denial; standard reviews are decided no later than 45 days after the request, expedited reviews no later than 72 hours; and "your insurer is required by law to accept the external reviewer's decision." Depending on your state and plan, the review runs through a state process or a federal one — note that healthcare.gov states that "As of July 1, 2026, the HHS-Administered Federal External Review Process (FERP) is temporarily unavailable" and that HHS is working on a solution — so check that page and your state insurance department for the process that currently applies to you.

The Medicare Part D track: different names, different clock

Medicare drug coverage uses its own multi-level process, laid out at medicare.gov and in CMS's Part D appeals rules (42 CFR Part 423, Subpart M). It starts before the appeal: you or your prescriber ask the plan for a coverage determination (including a formulary "exception"). If you request an exception, "your prescriber must provide a statement explaining the medical reason why the exception should be approved," per medicare.gov. If the answer is no, there are generally five appeal levels; each decision letter tells you how to reach the next.

Medicare readers: know about the GLP-1 Bridge

Separately from any appeal, CMS is running the Medicare GLP-1 Bridge, a demonstration from July 1, 2026 through December 31, 2027 giving eligible Part D enrollees access to certain GLP-1 drugs for a $50 monthly copay (the copay doesn't count toward deductibles or out-of-pocket limits). Check eligibility at Medicare.gov/glp1bridge or 1-800-MEDICARE — for some readers this route matters more than the appeal.

Medicaid and self-funded employer plans, briefly

Medicaid: programs "must follow federal guidelines, but eligible income levels, coverage, and costs may be different from state to state," per healthcare.gov — appeal procedures come from your state. Your denial notice and your state Medicaid agency are the authoritative sources for your deadlines. Self-funded employer plans: some employers pay claims themselves instead of buying an insurance policy. If yours does — HR can tell you — the appeal process may be run differently from the state-regulated one described above, so ask HR or the plan administrator exactly which internal appeal and external review process applies to you and where it is set out in your plan documents. Either way, the plan still has to tell you why it denied the claim and how to dispute it, per healthcare.gov.

What a strong appeal submission commonly includes

healthcare.gov's internal-appeals checklist says to include the Explanation of Benefits or denial letter, a copy of your appeal request, anything extra you sent the plan (like a letter from your doctor), and notes on every phone call — dates, times, names. For GLP-1 denials specifically, appeals commonly also include:

• A letter from the prescriber addressing the plan's stated denial reason point by point, with your BMI, relevant history, and documented prior weight-management attempts.
• The clinical evidence base for the prescribed drug — prescribers often cite trials such as STEP 1 (semaglutide: 14.9% average body-weight reduction at 68 weeks) or SURMOUNT-1 (tirzepatide: up to 20.9% at 72 weeks).
• The exact plan criteria you're being measured against (ask the plan for its clinical policy in writing) and evidence you meet each one.

No document guarantees an outcome — this is what complete submissions typically contain, not a template.

If the appeal fails: realistic next moves

Some appeals cannot win, especially against categorical exclusions. Realistic options: revisit coverage strategy at open enrollment using our GLP-1 insurance coverage guide; compare self-pay routes, including manufacturer direct-purchase programs, in our cost-without-insurance guide; ask your prescriber whether a different covered medication in the class fits your situation (see Wegovy vs. Zepbound and oral GLP-1 pills); and if you're on Medicare, check the GLP-1 Bridge above. More reader questions are answered in our GLP-1 FAQ for women.

Questions to ask your plan on the phone

• "Is this denial because I didn't meet clinical criteria, or because weight-loss medications are excluded from my benefit?"
• "Please send me, in writing, the exact clinical policy and criteria used to deny this request."
• "What is my deadline to file an internal appeal, and where do I send it?"
• "Does my situation qualify for an expedited appeal?"
• "After internal appeal, do I have external review — and is it a state or federal process?"
• "Is this plan self-funded or fully insured?" (Ask HR if the plan can't say.)
• "Can you give me a reference number for this call, and your name?"

Log every answer with date and time — healthcare.gov's appeal checklist tells you to keep exactly these notes. Your plan documents and your state insurance department remain the final word on the deadlines that apply to you.